We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Flow Cytometry Rapidly Determines Specific Interleukin-6 Activity

By LabMedica International staff writers
Posted on 29 Oct 2014
Print article
Image: PAR Cyflow-Space Software (Photo courtesy of Sysmex PARTEC)
Image: PAR Cyflow-Space Software (Photo courtesy of Sysmex PARTEC)
The measurement of the specific activity of a given cytokine often requires a time-consuming and tedious bioassay based upon its effect on the proliferation, chemotaxis, or toxicity of a factor-dependent cell line.

The determination of the specific activity of the cytokine interlukin-6 (IL-6) was accomplished by ascertaining the dose–response curve of the phosphorylation of a signaling protein that can be quantified by flow cytometry.

Immunologists at Héma-Québec (Montreal, QC, Canada) used the IL-6 model, as an approach for the determination of the specific activity of cytokines by determining the dose–response curve of the phosphorylation of the signaling protein Stat-3 pY705 for IL-6, in a responsive cell line subjected to different concentrations of the cytokine. The phosphorylation of the protein is quantified by flow cytometry. Since the signaling cascade only takes a few minutes to achieve following linking of the cytokine to its receptor, the whole procedure can be done in a few hours.

The scientists used the cell line 7TD1 (DSMZ, German Collection of Microorganisms and Cell Cultures GmbH; Braunschweig, Germany), which is an IL-6 dependent cell line. The cells were cultured in RPMI-1640 containing 5% fetal bovine serum (FBS) and 10 ng/mL of IL-6. To speed up flow cytometry, the samples were fluorescently barcoded by adding Pacific Blue and Alexa Fluor 488 to allow multiplex analysis. After processing the cells were analyzed on a Partec CyFlow ML flow cytometer (Swedesboro, NJ, USA).

The scientists were able to determine and compare the specific activity of commercial lots of IL-6 using the flow cytometry method. They observed significant differences both from lots from different manufacturers and lots from a same manufacturer, with an eightfold difference between the specific activity of the highest and lowest one. This demonstrated that in studies requiring accurate cytokine concentrations, determining the specific activity for each lot should be a crucial step in order to get reproducible results.

Higher levels of IL-6 have been observed in the blood of advanced or metastatic cancer patients and are associated with the development of encephalitis in children. The study was published on October 5, 2014, in the Journal of Immunological Methods.

Related Links:

Héma-Québec
German Collection of Microorganisms and Cell Cultures GmbH 
Partec


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.